share_log

Theriva Biologics Q3 EPS $(0.33) Beats $(0.39) Estimate

Theriva Biologics Q3 EPS $(0.33) Beats $(0.39) Estimate

Theriva Biologics第三季度每股收益(0.33)超過預期(0.39)
Benzinga Real-time News ·  2022/11/10 17:14

Theriva Biologics (AMEX:TOVX) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.39) by 15.38 percent. This is a 65 percent decrease over losses of $(0.20) per share from the same period last year.

Theriva Biologics(美國證券交易所股票代碼:TOVX)公佈季度每股虧損0.33美元,比分析師一致預期的每股虧損0.39美元高出15.38%。這比去年同期每股虧損0.20美元減少了65%。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論